Abortion pill makers brace for restrictions a year after Trump's election

Abortion pill makers brace for restrictions a year after Trump's election

Abortion medication access, like mifepristone, is unchanged under Trump, but FDA reviews, lawsuits and state enforcement are creating risks for drugmakers.

Abortion pill makers brace for restrictions a year after Trump’s election

In this article CVS WBA Follow your favorite stocksCREATE FREE ACCOUNTMifepristone and Misoprostol pills are pictured Wednesday, Oct. 3, 2018, in Skokie, Illinois.Erin Hooley | Chicago Tribune | Tribune News Service | Getty Images Just over a year since Donald Trump was elected president again, the $6.9 billion abortion pill industry is operating under the same federal rules he inherited from former President Joe Biden — but new threats to the …